top of page
Latest News
Search
HIV/HCV Co-Infection Watch Q2: April 2024
Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.
Ranier Simons
Apr 28, 202424 min read
HIV/HCV Co-Infection Watch Q1: January 2024
Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.
Ranier Simons
Jan 29, 202422 min read
HIV/HCV Co-Infection Watch Q2: April 2023
Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.
Jen Laws
Apr 23, 202326 min read
Xylazine: Advocates, Service Providers on High Alert
Xylazine contamination of drug supply demands harm reduction response including safe consumption sites.
Jen Laws
Jan 22, 20235 min read
Nevada Adds New Syringe Exchange Vending Machines, Building on Success
Nevada expands syringe vending machines with naloxone, fentanyl strips; anonymity critical for uptake.
Jen Laws
Nov 27, 20223 min read
HIV/HCV Co-Infection Watch Q3: July 2022
Q3 2022 review of HCV drug access across ADAPs, Medicaid, and comprehensive harm reduction programs.
Jen Laws
Jul 26, 202225 min read
Biden Drug Policy Agenda: NIH Invests in Harm Reduction
NIH issues RFAs for Harm Reduction Network; Biden agenda targets decriminalization and safe consumption.
Jen Laws
Jan 23, 20224 min read
HIV/HCV Co-Infection Watch Q3: July 2021
Q3 2021 quarterly review of HCV drug access across ADAPs and Medicaid with harm reduction program updates.
Jen Laws
Jul 22, 202119 min read
HIV/HCV Co-Infection Watch Q1: January 2021
Quarterly Watch covering HCV treatment access across ADAPs and Medicaid, harm reduction programs, and COVID-19 impact on care.
Jen Laws
Jan 24, 202122 min read
We Need Your Support Today!
bottom of page